Alarm as FDA willing to issue Covid-19 vaccine before stringent safety testing

FDA under intensifying pressure from Trump, who wants to see a vaccine come on stream or ready to announce before the election Public health experts have reacted with alarm to remarks by the head of the US Food and Drug Administration (FDA) that he might give the green light for a US Covid-19 vaccine before the normal clinical trial process had reached its conclusion. As the US was on the verge of 6m coronavirus cases on Sunday, Stephen Hahn, the FDA commissioner, told the Financial Times in an ...